Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02891993 · ClinicalTrials.gov registry record · NA

Pilot Study of a Symptom Monitoring Intervention for Hospitalized Patients With Cancer

A NA study of Cancer, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
150
Enrollment target
1
Study location

NCT02891993: Completed NA study of Cancer, sponsored by Massachusetts General Hospital.

NCT02891993 is a NA study of Cancer that has completed, run by Massachusetts General Hospital. The registered enrollment target is 150 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02891993, a NA study of Cancer, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to address the challenge of symptom management for hospitalized patients with cancer.

Conditions Studied

Cancer

Interventions

  • OTHER Usual Care
  • OTHER IMPROVED

Study Locations (1)

Massachusetts

  • Massachusetts general Hospital - Boston

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2016-09
Est. Completion 2017-12-14
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02891993

The ClinicalTrials.gov registry entry for NCT02891993 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (96% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.

NCT02891993 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02891993 about?

NCT02891993 is a clinical study titled "Pilot Study of a Symptom Monitoring Intervention for Hospitalized Patients With Cancer". The purpose of this research study is to address the challenge of symptom management for hospitalized patients with cancer.

What is the current status of trial NCT02891993?

This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2016-09. Estimated completion is 2017-12-14.

What conditions does trial NCT02891993 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT02891993?

The interventions under investigation include: Usual Care (OTHER), IMPROVED (OTHER).

Who is sponsoring clinical trial NCT02891993?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02891993 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Cancer

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.